Clinical trials
Hemorrhage trials in France with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 6 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 6 |
| Terminated | 5 |
| Active, not recruiting | 4 |
| Not yet recruiting | 3 |
| Unknown status | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Clermont-Ferrand | 4 |
| University Hospital, Grenoble | 2 |
| Abbott Medical Devices | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Biosensors Europe SA | 1 |
| Boston Scientific Corporation | 1 |
| CMC Ambroise Paré | 1 |
| Centre Hospitalier Régional Metz-Thionville | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemorrhage | 35 |
| Stroke | 3 |
| Atrial Fibrillation | 2 |
| Leiomyoma | 2 |
| Pain | 2 |
| Thrombosis | 2 |
| Aneurysm | 1 |
| Angiomyolipoma | 1 |
| Arterial Occlusive Diseases | 1 |
| Blood Coagulation Disorders | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.